¤E¤Q¦~«×¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ®ø¤Æ¬ì

(C) 1. ¦³Ãöµw¤ÆÁxºÞª¢(Sclerosing cholangitis)¡A¤U¦C¦óªÌ¬°»~¡H
A.¬°Áx¹D¤§¨}©Ê«D²Óµß©Êª¢©Ê¯U¯¶
B.±`¦X¨Ö¦³ºC©Ê¼ìºÅµ²¸zª¢
C.§Ü²É½uÅé§ÜÅé(Antimitochondrial antibody)¦h¼Æ¬°¶§©Ê
D.¸g¥Ö¬ï¨xÁx¹DÄá¼v©Î°f¦æ©ÊÁx¯ØºÞÄá¼v¦³§U©ó½T©w¶EÂ_
E.Cholestyramine¹ï¤îÄo¦³®Ä
 
(B) 2. ¸¡¤ô±wªÌ¡A¸gÀˬd¨ä¸¡¤ô¬°ª¢©Êº¯¥X²G(Exudate)¥B±a¦å¡A¬Á§¿»Ä(Hyaluronic acid)§t¶q°ª©ó0.25 mg/ml¡A¨ä¥i¯à¤§¶EÂ_¬°¡G
A.Secondary carcinomatosis
B.Primary mesothelioma
C.Pseudomyxoma peritonei
D.Granulomatous peritonitis
E.Sclerosing peritonitis
 
(E) 3. ¹ïºC©Ê¯ØŦª¢±wªÌ¤§³B²z¡A¤U¦C¦óªÌ¤£©y¡H
A.«æ©Êµo§@®É¸T­¹¤ÎÀR¯ß¿é²G
B.¨Ï¥Î³Â¾K¤îµhÃÄ(Narcotic analgesics)
C.¤fªA¯ØŦ³J¥Õ¤À¸Ñ»Ã¯À(Proteolytic enzyme)
D.¨Ï¥Î²Õ´Ói¨üÅé«ú§Ü¾¯(H2 receptor antagonist)
E.¨Ï¥Î§tÁâ¡B¶tµ¥¨î»Ä¾¯¡A¦pMgO¡ACalcium carbonate
 
(D) 4. ·R´þ¯f(AIDS)¦b¤p¸z¤§¤U¦C±Ô­z¡A¦óªÌ¦³»~¡H
A.§l¦¬¤£¨}¤Î¸¡Âm±`¨£
B.²Óµß¡BÅðµß¡B±H¥ÍÂ奤§·P¬V±`¨£
C.Kaposi¤ó¦×½F³y¦¨­G¸z¹D»Ùê
D.¤Q¤G«ü¸z¤Á¤ùÅã¥Üµ³¤ò¶w¤Æ¤Îª¢©Ê®û¼í¦b¼ß½¤¼h(Serosa)
E.¦³®É¥iµo²{²Õ´²Ó­M(Histiocyte)®û¼í¤Î§Ü»Ä©Êµß(Acid-fast organism)¦s¦b
 
(D) 5. ¦b¼ìºÅ©Êµ²¸zª¢»P§J¶©¤ó¯f(Crohn's Disease)§¡¥iµo²{¤§¯f²zÅܤƬO
A.«D³sÄò©Ê¼ìºÅ
B.úPºÞ§Î¦¨
C.²O¤Ú¾®¶°(Lymphoid aggregates)
D.ÁôºÛÁwºÅ(Crypt abscess)
E.¦×ªÞ¸~(Granuloma)
 
(C) 6. ¤U¦C¦³Ãö­¹¹D¤§±Ô­z¡A¦óªÌ¬°»~¡H
A.­¹¹D¤W¤T¤À¤§¤@¥Ñ¾î¯¾¦Ù¡A¤U¤T¤À¤§¤G¥Ñ¥­·Æ¦Ùºc¦¨
B.¦hµo©Ê¦Ùª¢(Polymyositis)«I¥Ç­¹¹D¤WºÝ
C.µw¥Ö¯f(Scleroderma)«I¥Ç¾ã¬q­¹¹D
D.­¹¹D¥¢¦¢¯g(Achalasia)«Yį°Ê¤£¨}¤Î¤U­¹¹D¬A¬ù¦ÙÃP¦¢²§±`
E.­G­¹¹D°f¬y¯f(GERD)«Y¤U­¹¹D¬A¬ù¦Ù¥¼¯à¦³®Ä¨¾¤î­G¤º®eª«¤Ï¬y
 
(C) 7. ¿ò¶Ç©Ê­G¸z®§¦×¯g¯g­Ô¸s¤¤¡Aµo¥Í©óµ²¸z¡A²Õ´§ÎºA¬°¸¢½F¡A©ö¦ñÀHµo¥Í¤¤¼Ï¯«¸g´c©Ê¸~½FªÌ¬O
A.Familial colonic polyposis
B.Gardner's Syndrome
C.Turcot's Syndrome
D.Nonpolyposis Syndrome
E.Peutz-Jegher's Syndrome
 
(D) 8. ¦UºØ¯ØŦ¤º¤Àªc¸~½F¤¤¡A¯f²z¤W¬°Delta cell islet tumor¡AÁ{§É¤W¦³¸¡Âm¡B¯×ªÕ«K¡AÁxµ²¥Û¡A¿}§¿¯f¤Î³h¦åµ¥ªÌ¬O
A.Zollinger-Ellison Syndrome
B.Insulinoma
C.Glucagonoma
D.Somatostatinoma
E.Carcinoid
 
(E) 9. Acetaminophen¾É­P¤§ÃĪ«©Ê¨xª¢¡A¤U¦C±Ô­z¡A¦óªÌ¦³»~¡H
A.³æ¦¸Á`¾¯¶q10¦Ü15¤½§J§Y¥i¯à¤ÞµoÁ{§É¨x·l¶Ë²{¶H
B.¼ç¥ñ´Áµu
C.äú¤ß¡B¹Ã¦R¡B¸¡Âm¡B¸¡µh¤Î¥ð§J¬°¦­´Á¯gª¬
D.¤£·|¦X¨Ö¦³¥Ö½§¯l¡BÃö¸`µh¤Î¶Ý¥ì¬õ¦å¯gµ¥
E.¨xŦ¯f²z§ÎºA»P¯f¬r©Ê¨xª¢Ãþ¦ü
 
(D) 10. Cisapride¬°¤@­G¸zį°Ê«P¶i¾¯¡A¦³Ãö¨ä¤U¦C±Ô­z¡A¦óªÌ¬°»~¡H (1)¬°5-HT4¨üÅé«P¶i¾¯ (2)»PMetoclopramide¬Û¦P¡A¨ã¤î¦R©ÎÂíÀR§@¥Î (3)¤Þ°_¤ß«ß¤£¾ã¥HÄu©Ê¤ß·i¹L½w³Ì±`¨£ (4)»PCimetidine¦X¥Î¡A¨ä¦å¤¤¿@«×­°§C (5)»P¬Y¨Ç§Ü¥Í¯À¡B§Ü¼~Æ{ÃÄ¡B§ÜÅðµßÃĦ³ÃĪ«¥æ¤¬§@¥Î
A.1+2
B.2+3
C.3+4
D.2+3+4
E.3+4+5
 
(E) 11. ¦³Ãö¦Ûµo²Óµß©Ê¸¡½¤ª¢(Spontaneous bacterial peritonitis)¤§±Ô­z¡A¦óªÌ¦³»~¡H(1)©öµo¥Í©ó¸¡¤ô¤º³J¥Õ°ªªÌ (2)¬ðµMµo¥Í¨x©Ê¸£¯fÅܤΧC¦åÀ£®É»ÝÃhºÃ¦¹¯g (3)³q±`¦³µo¿N¡B¸¡µh¤Î¸¡³¡À£µh (4)²Óµß«Y¥Ñ²O¤Ú©Î¦å²G©Î¬ï¹L¸z¾À¨ì¸¡µÄ (5)¸¡¤ôpH­È°ª©ó¦å²GpH­È
A.1+2
B.2+3
C.3+4
D.4+5
E.1+5
 
(D) 12. ¹ï©óÁxÅnµ²¥Û(gallstone)¤§³B¸m¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.µL¯gª¬ªÌ³q±`¤£»Ý³B¸m
B.´¿µo¥Í«æ©ÊÁxÅnª¢ªÌ¡AÀ³¦Ò¼{¶}¤M¤Á°£ÁxÅn
C.¸¡µÄÃèÁxÅn¤Á°£³N¬O¥Ø«e³Ì±`¥Îªº¤â³Nªk
D.Åé¥~¾_ªi¸H¥Û¦X¨ÖUDCA(ursodeoxycholic acid)ªvÀø¤]«Ü±`¥Î
E.­Yµ²¥Û¨S¦³¶t¤Æ(radiolucent stone)¡A¤p©ó10 mm¡A¨Ï¥ÎUDCAªvÀø¬ù¦³50%¥ª¥kªº¯f¤H¨äµ²¥Û·|®ø¥¢
 
(A) 13. ¤@¦ì¯f¤H¦]¶À¯n¦í°|¡C¨ä¯f¥v¤¤Åã¥Ü¹L¥h¤£©w®É·|¦³¥k¤W¸¡µh¤Î¯ù¦â§¿¤§²{¶H¡A¦ý¨Ã¥¼¥[¥Hª`·N¡C¦í°|«á¡AERCP(endoscopic retrograde cholangiopancreaticography)Åã¥Ü¨ä¨x¤ºÁxºÞ§e©À¯]ª¬(beaded appearance)¡C¦³Ãö¥»¯f¤H¤§±Ô­z¡A¤U¦C¦óªÌ¿ù»~¡H
A.¨äªvÀøÀ³¥]¬AUDCA(ursodeoxycholic acid)¤ÎÃþ©T¾J
B.À³ª`·N¨ä¦³µL¦X¨Öinflammatory bowel disease
C.¯f¤H¤§¦~Ä֤Φå²MÁx¬õ¯À­È»P¨ä¹w«á¦³Ãö
D.¨ä©¹«á¤§°lÂÜÀ³ª`·Ncholangiocarcinoma¤§µo¥Í
E.»Ý¦Ò¼{¨xŦ²¾´Ó
 
(E) 14. Ãö©ógallstone ileus¤§±Ô­z¡A¤U¦C¦óªÌ¿ù»~¡H
A.¬O¤@ºØmechanical ileus
B.¬OÁxÅnµ²¥ÛÂ÷¶}ÁxÅn¶i¤J­G¸z¹D«á³y¦¨ªº¯e¯f
C.¤j©ó2.5¤½¤Àªºµ²¥Û¸û©ö³y¦¨¦¹ºØ¯fªp
D.³oºØ¯f¤H±`¦³cholecystoenteric fistula
E.³q±`¦Û¤v·|²¬Â¡¡A¤£»Ý¶}¤M
 
(C) 15. ¤@¦ì¯f¤H¦]µo¿N¤Î¸¡µÈ¦Ó¦í°|¡C²z¾ÇÀˬdµo²{¦³shifting dullness¡A¥B¸¡³¡¦³À£µh¤Î¤Ï¼uµh¤§²{¶H¡C©â¨ú¸¡¤ô°eÅç¡Aµo²{¨ä¤º¤§WBC¼Æ¥Ø¬°1000­Ó/£gL¡A¨ä¤¤PMN¦û80%¡C¤U¦C¦U¶µ±Ô­z¡A¦óªÌ¿ù»~¡H
A.¥»¯f¤H¤§¸¡½¤ª¢¡A³Ì¥i¯à¬OGram-negative²Óµß©Ò¤Þ°_ªº
B.­º¿ï§Ü¥Í¯À¬°Cefotaxime¥[aminoglycoside
C.ªvÀø´Á¶¡¤@¯ë¥H5¤Ñ¬°·Ç
D.¸¡¤ô¤¤³J¥Õ½è¿@«×¤p©ó1g/dLªÌ¡AÀ³ª`·N¸¡½¤ª¢¤§´_µo
E.­¹¹DÀR¯ß¦±±i(esophageal varices)¥X¦åªÌ¡A¸û©öµo¥Í²Óµß©Ê¸¡½¤ª¢
 
(A) 16. Ãö©óisoniazid¤§¨x¬r©Ê¡A¤U¦C±Ô­z¦óªÌ¿ù»~¡H
A.¹ïisoniazid¦b¨x¤º¥NÁ¸ûºCªÌ(slow acetylators)¸û©öµo¥Í¨x¬r©Ê
B.10%¥ª¥k¤§±wªÌ©ó¶}©lªA¥Îisoniazid¼Æ¶g«á¥X²{¨x¬r©Ê
C.³q±`¥iÄ~ÄòªA¥Î¡A¨ä¨x¬r©Ê·|ºCºC®ø¥¢
D.¦³¨Ç¯f±w²£¥Í¤§¨x¬r©Ê¸ûÄY­«¡A»P±wªÌ¤§¦~ÄÖ¦³Ãö
E.rifampicin¨Ö¥Î·|¥[±j¨ä¨x¬r©Ê
 
(C) 17. ¯f¤H¦]¦R¦å³Q°e¦ÜÂå°|«æ¶E«Ç¡Aºò«æ³B¸m¨Ï¯f±¡Ã­©w«á¡A¦w±Æ¤ºµøÃèÀˬd¡Aµo²{¬°­¹¹DÀR¯ß¦±±i(esophageal varices)¥X¦å¡C±z¬O³o¦ì¯f¤Hªº¥DªvÂå®v¡A±ýÀ°¨ä¦w±Æ¸¡³¡¶W­µªi¤Î³£¤R°Ç¶W­µªiÀˬd¡A§Æ±æÀˬdªºÂå®v¼á²M¬O§_¦³¤U¦C¦UºØ¥i¯àªº¯fªp¡A°£¤F¡G
A.¨xµw¤Æ
B.¨xªù¯ß®ê¶ë(thrombosis)
C.¤W¸zô½¤ÀR¯ß(superior mesenteric vein)®ê¶ë
D.¨x°Ê¯ß»P¨xªù¯ß¶¡²§±`¥æ¬y¡A¾É­P¨xªù¯ß¥D·F(portal trunk)¦å¬y°f¬y
E.¨xÀR¯ß¤Î¤UµÄÀR¯ß²§±`
 
(B) 18. ¤@¦ì¯f¤H¦]·NÃѤ£²M¦Ó¦í¶i¯«¸g¬ì¯f©Ð¡AÀˬdµ²ªGµo²{¨ä¦å¤¤ammonia­È©úÅã¤É°ª¡AAlbumin=3.5(>3.5 g/dL)¡ABilirubin(T/D)=1.1/0.4(<1.0/>0.4 mg/dL)¡AGOT(AST)=35(<41)¡AGPT(ALT)=31(<41)¡Aprothrombin time=13.5"(11.5")¡C½Ð°Ý³o¦ì¯f¤H³Ì¥i¯à¦³¤U¦C¦óºØ¯fªp¡H
A.ÄY­«¨xµw¤Æ
B.ÄY­«¨xªù¯ß°ªÀ£¨Ö¦³°¼ªK´`Àô
C.Budd-Chiari syndrome
D.Hepatic artery - hepatic vein shunting
E.Splenic artery - splenic vein shunting
 
(C) 19. Ãö©óHEV(hepatitis E virus)¤§±Ô­z¡A¤U¦C¦óªÌ¿ù»~¡H
A.¬°RNA¯f¬r¡A¨äÁû²Éª½®|¬°32~34 nm¡A°ò¦]Å鬰7.6 kb
B.¨ä¶Ç¬V¬°fecal-oral route
C.¨ä¼ç¥ñ´Á¬°30~180¤Ñ¡A¥­§¡60~90¤Ñ
D.¤@¯ë¤H·P¬VHEV«á¡Aµo¥Í²rÃz©Ê¨xª¢¤§¾÷²v¬°1~2%
E.¤£·|ºtÅܦ¨ºC©Ê¨xª¢
 
(D) 20. Interferon-£\¦X¨ÖRibavirin¤§ªvÀøªk¬O²{¦b¹ïºC©ÊC«¬¨xª¢¤§³Ì¨ÎÀøªk¡A¤U¦C¦U¶µ±Ô­z¡A¦óªÌ¥¿½T¡H(1)decompensated cirrhosis¯f¤HÀ³¾¨§Ö±µ¨üªvÀø (2)­ì¦³³h¦å¡B«aª¬°Ê¯ß¯e¯f¡A©ÎºC©ÊµÇ¥\¯à¤£¥þ¤§¯f¤H¤£¯à±µ¨ü¦¹ºØÀøªk (3)HCV genotype 2¹ï¦¹Àøªk¤§®ÄªG¸û®t (4)¥¿±µ¨üimmunosuppressive agentªÌ¤£¾A¦X±µ¨ü¦¹Àøªk (5)±µ¨üªvÀø«á¹F¨ì½w¸ÑªÌ(¦å¤¤ALT¡BAST¥¿±`¡AHCV RNA®ø¥¢)¡A¨ä¨x²Ó­MÀù¤§µo¥Í¾÷²v·|­°§C
A.1+2+3+4
B.1+2+4+5
C.2+3+5
D.2+4+5
E.1+3
 
(A) 21. Ãö©ó«æ©Ê¯ØŦª¢¤§¶EÂ_©MªvÀø¡A¤U¦C±Ô­z¦óªÌ¥¿½T¡H (1)¦å²M¾ý¯»úC(amylase)¤§ÀËÅ礴¬O³Ì¤è«Kªº¤èªk¡A¯S§O¬O·í¨ä¼Æ­È¤j©ó¥¿±`­È¤W­­¤T­¿¥H¤W®É¡A¨ä¶EÂ_»ù­È¬Æ°ª (2)­Y¯f¤H¦³ºC©ÊµÇŦ¥\¯à¤£¥þ¡A³Ì¦n´ú¦å²M¯×ªÕúC(lipase) (3)contrast-enhanced dynamic CT (CECT) scan¹ï¯f±¡¤§ÄY­««×¤Î¹w«á¤§§PÂ_«Ü¦³»ù­È (4)¨C¤@¦ì¯f¤HÀ³¸T­¹¡A¨Ã©ñ»ó­GºÞ
A.1+2+3
B.1+2+4
C.2+3+4
D.1+3+4
E.1+2+3+4
 
(D) 22. Ãö©ó¦ÛÅé§K¬Ì¨x¯f¤Î¨ä¬ÛÃö¦ÛÅé§ÜÅ餧²Õ¦X¡A¤U¦C¦óªÌ¥¿½T¡H (1)¦ÛÅé§K¬Ì¨xª¢²Ä¤@«¬¡GANA (antinuclear antibody) (2)¦ÛÅé§K¬Ì¨xª¢²Ä¤T«¬¡Ganti-LKM3(antibody to liver-kidney microsomes) (3)Primary biliary cirrhosis¡Gmicrosomal antibody (4)Primary sclerosing cholangitis¡Gp-ANCA(peripheral antineutrophil cytoplasmic antibody)
A.1+2
B.2+3
C.3+4
D.1+4
E.1+3
 


< ¤E¤Q¦~«×¸ÕÃD¥Ø¿ý >